Please provide your email address to receive an email when new articles are posted on . BALTIMORE — The use of insulin pens varies widely from hospital to hospital, and teaching strategies for ...
4don MSN
Dr. Reddy’s Lab launches India’s first DCGI-approved semaglutide injection for type 2 diabetes
Dr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian ...
The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...
TOKYO, Feb. 20, 2025 /PRNewswire/ -- CSL Behring K.K. (Headquarters: Minato-ku, Tokyo; President and Representative Director: Izumi Yoshida) today announced that it has received manufacturing and ...
Addition of EasyFlow™ Technology to BD Ultra-Fine™ Nano™ 4mm Pen Needles Increases Confidence and Convenience of Injections FRANKLIN LAKES, N.J., June 21, 2013 /PRNewswire/ -- BD Medical, a segment of ...
TOKYO, Feb 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced that they have obtained ...
Hoogma RPLM et al. (2005) Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results